Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

DCP Participation at American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024

Date Posted

Consider attending these AACR sessions to learn about the latest DCP funding opportunities in cancer prevention, interception, and symptom science; research resources and workforce activities; multi-cancer detection tests and risk screening; future research needs; and more.

See also

DCP/PREVENT-funded Project Presentations at the 2024 AACR Annual Meeting

Saturday, April 6, 12:30 p.m. - 2:00 p.m.

Session type: Educational
Title: DC06: Rethinking Risk and Risk Assessment for Liquid Biopsy-Based Single- and Multi- Cancer Screening
Moderator
Lauren C. Leiman, Executive Director, BLOODPAC, Charleston, IL

Panelists
Jeff D. Allen, President & CEO, Friends of Cancer Research, Washington, DC

Christina A. Clarke, GRAIL, Menlo Park, CA

Elizabeth K. O'Donnell, Dana-Farber Cancer Institute, Boston, MA

Bree Mitchell, Natera, San Carlos, CA

Wendy Rubinstein, M.D., Ph.D., National Cancer Institute (NCI), National Institutes of Health (NIH)

Sunday, April 7, 2:30 p.m. - 3:30 p.m.

Session type: NCI/NIH Sponsored
Title: NIH02: Early-Onset Cancers from Etiology to Survivorship: Funding Opportunities, Resources, and Future Research Needs
Moderator: Asad Umar, D.V.M., Ph.D., NCI, NIH

Welcome and meeting overview
Naoko Ishbe, NCI, NIH

High-level overview of early-onset cancers
Tomotaka Ugai, Brigham and Women’s Hospital, Boston, MA

Patient/survivor perspective
Phuong Gallagher, USC Norris Comprehensive Cancer Center, Pasadena, CA

Funding Opportunities, NCI portfolio analysis on early-onset cancer
Anil Wali, NCI, NIH

Sunday, April 7, 3:00 p.m. - 5:00 p.m.

Session type: Mini symposium
Title: Multi-Cancer Early Detection Testing: Where Are We?
Co-Chairs: Wendy Rubinstein, M.D., Ph.D., NCI, NIH, and Marie Wood, M.D., Alliance for Clinical Trials in Oncology

Monday, April 8, 10:15 a.m. - 11:15 a.m.

Session type: NCI/NIH Sponsored
Title: NIH04: NCI Funding Opportunities in Cancer Prevention and Interception
Moderator: Robert H. Shoemaker, Ph.D., NCI, NIH

Introduction
Robert H. Shoemaker, Ph.D., NCI, NIH

Discovery and development of natural products for cancer interception and prevention (DDNP-CIP) Altaf Mohammed, Ph.D., NCI, NIH

Cancer immunoprevention network (CIP-Net)
Lillian Kuo, Ph.D., NCI, NIH

Cancer immunoprevention network (CIP-Net)
Altaf Mohammed, Ph.D., NCI, NIH

PREVENT program
Vignesh Gunasekharan, Ph.D., NCI, NIH

Monday, April 8, 6:00 p.m. - 8:00 p.m.

Session type: Town Meeting
Title: TM03: Perspectives in Cancer Prevention: Global and Early Detection Approaches: A Cancer Prevention Working Group Town Hall - Dedicated to the Memory of David S. Alberts
Invited Speaker
Phil Castle, Ph.D., NCI, NIH

Tuesday, April 9, 10:15 a.m. - 11:45 a.m.

Session type: Minorities in Cancer Research (MICR) Scientific Symposium
Title: Reducing cancer disparities in the era of multi-cancer early detection (MCED) tests

Achieving equity through the design of the NCI’s Vanguard Study
Phil Castle, Ph.D., NCI, NIH

Tuesday, April 9, 4:00 p.m. - 5:00 p.m.

Session type: NCI/NIH Sponsored
Title: NIH11: NCI Division of Cancer Prevention Research Resources, Funding Opportunities, and Research Workforce Activities
Moderator: Shanen M. Sherrer, Ph.D., NCI, NIH

Introduction
Jessica M. Faupel-Badger, Ph.D., M.P.H., NCI, NIH

NCI DCP support and resources for preclinical research
Shanen M. Sherrer, Ph.D., NCI, NIH

NCI DCP support and resources for preclinical research
Jessica M. Faupel-Badger, Ph.D., M.P.H., NCI, NIH

NCI DCP support and resources for clinical research
Brandy Heckman-Stoddard, Ph.D., M.P.H., NCI, NIH

Symptom science and DCP workforce initiatives
Brandy Heckman-Stoddard, Ph.D., M.P.H., NCI, NIH

Symptom science and DCP workforce initiatives
Jessica M. Faupel-Badger, Ph.D., M.P.H., NCI, NIH

Symptom science and DCP workforce initiatives
Shanen M. Sherrer, Ph.D., NCI, NIH

Poster Session Presentation

Title: Emergence of frameshift mutations during tumorigenesis in VCMsh2 mouse model of Lynch syndrome
Author: Yurong, Song, NCI, NIH
Session Category: Tumor Biology
Session Title: Animal Models of Cancer
Session Date and Time: Monday April 8, 2024, 9:00 a.m. - 12:30 p.m.
Location: Poster Section 6
Poster Board Number: 16
Published Abstract Number: 1445